Literature DB >> 7538486

Variation outside variable segments of the major outer membrane protein distinguishes trachoma from urogenital isolates of the same serovar of Chlamydia trachomatis.

E H Frost1, S Deslandes, D Gendron, D Bourgaux-Ramoisy, P Bourgaux.   

Abstract

OBJECTIVES--Whereas serovars A, B, Ba and C of Chlamydia trachomatis are usually associated with trachoma, two of these serovars (Ba and C) are occasionally observed in urogenital infections. Variation in the gene encoding the major outer membrane protein (MOMP) was explored to distinguish urogenital from trachoma specimens of the same serovar. METHODS--A large portion of the MOMP gene was amplified by nested PCR directly from clinical samples from trachoma or urogenital infection and the serovar of the infecting C trachomatis was determined by restriction fragment length polymorphism (RFLP). Amplified DNA from trachoma serovars B, Ba and C and from urogenital serovars Ba, C, D and E was sequenced by the dideoxy chain termination method. RESULTS--While almost identical in variable segment (VS)I, three urogenital Ba samples differed from all trachoma B and Ba samples at eight nucleotides including two sites which changed amino acids in the constant region upstream of VSI. An identical sequence in this region was observed for the reference urogenital D serovar. Variation in this same region upstream of VSI also distinguished 40% of serovar D samples from prototype D including three that were sequenced. Two urogenital C differed from trachoma C samples at four sites that changed the MOMP amino acid sequence including two changes in the constant region between VSII and III and single changes in VSII and III. On the basis of these sequence determinations, RFLP was predicted which allowed extension of these observations to 20 other urogenital Ba, 12 trachoma B or Ba, seven variant D, 12 D, four urogenital C and three trachoma C samples without further sequencing. CONCLUSION--Urogenital Ba and C samples have VSI or II and III sequences identical or very similar to trachoma strains of the same serovar, but resemble more closely other serovars in the constant regions. Urogenital serovar D samples can also be divided into two genotypes on the basis of sequence differences in the constant region preceding VSI.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7538486      PMCID: PMC1195363          DOI: 10.1136/sti.71.1.18

Source DB:  PubMed          Journal:  Genitourin Med        ISSN: 0266-4348


  15 in total

1.  Complete sequence of the major outer membrane protein-encoding gene of Chlamydia trachomatis serovar Da.

Authors:  C Sayada; E Denamur; J Elion
Journal:  Gene       Date:  1992-10-12       Impact factor: 3.688

2.  Antigenic determinants of the chlamydial major outer membrane protein resolved at a single amino acid level.

Authors:  G M Zhong; R C Brunham
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

3.  Mapping antigenic domains expressed by Chlamydia trachomatis major outer membrane protein genes.

Authors:  W Baehr; Y X Zhang; T Joseph; H Su; F E Nano; K D Everett; H D Caldwell
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

4.  Nucleotide and deduced amino acid sequences for the four variable domains of the major outer membrane proteins of the 15 Chlamydia trachomatis serovars.

Authors:  Y Yuan; Y X Zhang; N G Watkins; H D Caldwell
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

5.  Comparison of the major outer membrane protein variant sequence regions of B/Ba isolates: a molecular epidemiologic approach to Chlamydia trachomatis infections.

Authors:  D Dean; J Schachter; C R Dawson; R S Stephens
Journal:  J Infect Dis       Date:  1992-08       Impact factor: 5.226

6.  Diversity of Chlamydia trachomatis major outer membrane protein genes.

Authors:  R S Stephens; R Sanchez-Pescador; E A Wagar; C Inouye; M S Urdea
Journal:  J Bacteriol       Date:  1987-09       Impact factor: 3.490

7.  Typing Chlamydia trachomatis by detection of restriction fragment length polymorphism in the gene encoding the major outer membrane protein.

Authors:  E H Frost; S Deslandes; S Veilleux; D Bourgaux-Ramoisy
Journal:  J Infect Dis       Date:  1991-05       Impact factor: 5.226

8.  Chlamydia trachomatis serovar differentiation by direct sequence analysis of the variable segment 4 region of the major outer membrane protein gene.

Authors:  E Poole; I Lamont
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

9.  Genotyping of Chlamydia trachomatis from a trachoma-endemic village in the Gambia by a nested polymerase chain reaction: identification of strain variants.

Authors:  L J Hayes; R L Bailey; D C Mabey; I N Clarke; M A Pickett; P J Watt; M E Ward
Journal:  J Infect Dis       Date:  1992-11       Impact factor: 5.226

10.  Sensitive detection and typing of Chlamydia trachomatis using nested polymerase chain reaction.

Authors:  E H Frost; S Deslandes; D Bourgaux-Ramoisy
Journal:  Genitourin Med       Date:  1993-08
View more
  14 in total

1.  Population-based genetic and evolutionary analysis of Chlamydia trachomatis urogenital strain variation in the United States.

Authors:  Kim Millman; Carolyn M Black; Robert E Johnson; Walter E Stamm; Robert B Jones; Edward W Hook; David H Martin; Gail Bolan; Simon Tavaré; Deborah Dean
Journal:  J Bacteriol       Date:  2004-04       Impact factor: 3.490

2.  Molecular and mutation trends analyses of omp1 alleles for serovar E of Chlamydia trachomatis. Implications for the immunopathogenesis of disease.

Authors:  D Dean; K Millman
Journal:  J Clin Invest       Date:  1997-02-01       Impact factor: 14.808

3.  Serotyping and genotyping of genital Chlamydia trachomatis isolates reveal variants of serovars Ba, G, and J as confirmed by omp1 nucleotide sequence analysis.

Authors:  S A Morré; J M Ossewaarde; J Lan; G J van Doornum; J M Walboomers; D M MacLaren; C J Meijer; A J van den Brule
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

4.  Sensitivity of a commercial polymerase chain reaction for different serovars of Chlamydia trachomatis present at low titre in clinical samples.

Authors:  E H Frost; S Deslandes; D Bourgaux-Ramoisy; P Bourgaux
Journal:  Genitourin Med       Date:  1995-10

5.  Phylogenetic analysis of Chlamydia trachomatis Tarp and correlation with clinical phenotype.

Authors:  Erika I Lutter; Christine Bonner; Martin J Holland; Robert J Suchland; Walter E Stamm; Travis J Jewett; Grant McClarty; Ted Hackstadt
Journal:  Infect Immun       Date:  2010-07-06       Impact factor: 3.441

Review 6.  Diagnosis and assessment of trachoma.

Authors:  Anthony W Solomon; Rosanna W Peeling; Allen Foster; David C W Mabey
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

7.  Characterization of ompA genotypes by sequence analysis of DNA from all detected cases of Chlamydia trachomatis infections during 1 year of contact tracing in a Swedish County.

Authors:  Maria Lysén; Anders Osterlund; Carl-Johan Rubin; Tina Persson; Ingrid Persson; Björn Herrmann
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

8.  Polymorphisms in Chlamydia trachomatis tryptophan synthase genes differentiate between genital and ocular isolates.

Authors:  Harlan D Caldwell; Heidi Wood; Debbie Crane; Robin Bailey; Robert B Jones; David Mabey; Ian Maclean; Zeena Mohammed; Rosanna Peeling; Christine Roshick; Julius Schachter; Anthony W Solomon; Walter E Stamm; Robert J Suchland; Lacey Taylor; Sheila K West; Tom C Quinn; Robert J Belland; Grant McClarty
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

9.  Characterization of Chlamydia trachomatis omp1 genotypes detected in eye swab samples from remote Australian communities.

Authors:  Matthew P Stevens; Sepehr N Tabrizi; Rosanne Muller; Vicki Krause; Suzanne M Garland
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

10.  Effect of serial passage in tissue culture on sequence of omp1 from Chlamydia trachomatis clinical isolates.

Authors:  D R Stothard; B Van Der Pol; N J Smith; R B Jones
Journal:  J Clin Microbiol       Date:  1998-12       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.